Thrombin receptors and their antagonists: an update on the patent literature - Wikidata - awgldk - TriplyDB

Thrombin receptors and their antagonists: an update on the patent literature

Thrombin receptors and their antagonists: an update on the patent literature

http://www.wikidata.org/entity/Q28281696

about

Distinct activation modes of the Relaxin Family Peptide Receptor 2 in response to insulin-like peptide 3 and relaxin Role of G protein-coupled receptors in inflammation.Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells Aptamers as therapeutics in cardiovascular diseases.Prolinamide derivatives as thrombin inhibitors for the treatment of thrombin-mediated diseases: a patent evaluation of US2013296245.Relationship between G proteins coupled receptors and tight junctions.Protease activated receptor-1 antagonist ameliorates the clinical symptoms of experimental autoimmune encephalomyelitis via inhibiting breakdown of blood-brain barrier.

P2860

Q33789816-B8F4C791-27E8-4151-BC4C-9DCA365EAAA9 Q33858841-CA517911-4E7E-4939-9FC4-39ED60105229 Q36919773-21D7BC62-6969-49E3-9FF6-5F9217EB2664 Q37919102-65FBD1D6-C05D-4CE6-8AC6-B8B741519FF6 Q38251303-FD4BCDA2-7814-4B93-9937-5BD3E9DF3000 Q50116104-D49F271E-351D-4E42-BCDE-097E66374324 Q52923632-4AA7A45E-54D9-4382-8286-DB1E6A75161A

P2860

Thrombin receptors and their antagonists: an update on the patent literature

http://www.wikidata.org/entity/Q28281696

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Thrombin receptors and their antagonists: an update on the patent literature

@ast

Thrombin receptors and their antagonists: an update on the patent literature

@en

Thrombin receptors and their antagonists: an update on the patent literature

@nl

type

label

Thrombin receptors and their antagonists: an update on the patent literature

@ast

Thrombin receptors and their antagonists: an update on the patent literature

@en

Thrombin receptors and their antagonists: an update on the patent literature

@nl

prefLabel

Thrombin receptors and their antagonists: an update on the patent literature

@ast

Thrombin receptors and their antagonists: an update on the patent literature

@en

Thrombin receptors and their antagonists: an update on the patent literature

@nl

P1433

Q28281696-039D26ED-13D9-476A-9D40-B0512FFDAA7C

P1476

Q28281696-229820DF-2A4F-4226-A382-4C582FD9521F

P2093

Q28281696-0397AEB1-B84D-4FF1-915B-007870B4B5EB

P2860

Q28281696-0239C49D-241B-4BA6-AFD3-79F5423B4D8A

Q28281696-07D3832A-6F39-4494-9D49-9D7D1923C274

Q28281696-0929DC27-526C-471D-BBB1-F2A9F6013726

Q28281696-0CC53D43-E860-4ACD-B91B-2FD504D37250

Q28281696-0E75A372-81E7-41E3-B8FA-A8BEEB4530CB

Q28281696-111C36C4-5613-4C51-85A3-CF3B108DCB3C

Q28281696-1A6654F7-E67C-4BC3-8684-CCFAA0C932D4

Q28281696-2AEF7CEC-2255-455F-8EA7-A3FA59A3108B

Q28281696-2DB2F4EA-5502-4A78-809E-C045D3D660E6

Q28281696-3766A81E-186B-4625-B881-3C76A42BCBF3

P304

Q28281696-D2EC4E3E-E0D5-4962-BBD4-37290A9A4AEE

P31

Q28281696-56A58D56-3749-4024-B09E-EF74D877CF13

P3181

Q28281696-BB521F75-E641-4D3C-962F-FA0D54386135

P356

Q28281696-9BFA82C7-124F-451B-8EEC-9E6905FACB25

P407

Q28281696-057A43EE-8527-4951-A48E-EEA3AD4ECCF6

P433

Q28281696-495619EB-D794-402D-A234-B2E67F93A20F

P478

Q28281696-F424601C-40CA-4836-A6B4-CD3B52E78003

P50

Q28281696-6D22E00A-0659-49F7-AFF4-61ADEE15D6B4

P577

Q28281696-006226A9-88E5-4087-A4FC-4A064A80DBDA

P5875

Q28281696-71783F1F-EBFF-42AF-9914-CCD530A2A0E3

P698

Q28281696-F37681C8-AA00-4457-9C62-3E2587142094

P3181

P356

13543776.2010.487864

P1433

Expert Opinion on Therapeutic Patents

P1476

Thrombin receptors and their antagonists: an update on the patent literature

@en

P2093

Beatrice Severino

http://www.w3.org/2001/XMLSchema#string

P2860

Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides

Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells

Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor

YD-3, a novel inhibitor of protease-induced platelet activation

Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor

Thrombin receptor (PAR-1) antagonists. Solid-phase synthesis of indole-based peptide mimetics by anchoring to a secondary amide.

Inhibiting protease-activated receptor 4 limits myocardial ischemia/reperfusion injury in rat hearts by unmasking adenosine signaling.

Protease-activated receptors in inflammation, neuronal signaling and pain.

Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation.

Discovery of a novel, orally active himbacine-based thrombin receptor antagonist (SCH 530348) with potent antiplatelet activity.

P304

875-84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1568266

http://www.w3.org/2001/XMLSchema#string

P356

10.1517/13543776.2010.487864

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Giuseppe Cirino

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44580553

http://www.w3.org/2001/XMLSchema#string

P698

20450349

http://www.w3.org/2001/XMLSchema#string